Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014)
Vertex Pharmaceuticals (VRTX) recorded quarterly Current Taxes of $14.2 million in Q4 2014, up 1886.85% quarter-over-quarter from $715000.0 in Q4 2012.
Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014) Analysis & Trends
Vertex Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $14.2 million for Q4 2014.
- In Q4 2014, Current Taxes changed N/A year-over-year to $14.2 million; the TTM figure through Dec 2014 stood at $14.2 million (changed N/A YoY), while the FY2014 annual figure was $14.2 million, changed N/A from the prior year.
- Current Taxes was $14.2 million for Q4 2014 at Vertex Pharmaceuticals, up from $715000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $14.2 million in Q4 2014 to a low of $201000.0 in Q1 2012.
- Historically, Current Taxes has averaged $5.9 million across 3 years, with a median of $3.9 million in 2012.
- Biggest YoY gain for Current Taxes was 60.32% in 2012; the steepest drop was 94.08% in 2012.
- A 3-year view of Current Taxes shows it stood at $12.1 million in 2011, then plunged by 94.08% to $715000.0 in 2012, then jumped by 1886.85% to $14.2 million in 2014.
- The last three Current Taxes figures came in at $14.2 million (Q4 2014), $715000.0 (Q4 2012), and $3.9 million (Q3 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 14.21 Mn |
| Dec 31, 2012 | 715,000.00 |
| Sep 30, 2012 | 3.87 Mn |
| Jun 30, 2012 | 201,000.00 |
| Mar 31, 2012 | 201,000.00 |
| Dec 31, 2011 | 12.08 Mn |
| Sep 30, 2011 | 9.76 Mn |